C6 Ceramide NanoLiposome (CNL)

C6 ceramide nanoLiposome · Keystone Nano, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for C6 Ceramide NanoLiposome (CNL), covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]